Press Releases

S. 1413 and H.R. 2725 would exempt future FDA user fees from sequestration.

BIO Jobs is your online resource for biotechnology employment opportunities.

BIO released a statement in support of the FDA Safety Over Sequestration Act (H.R. 2725), which would exempt user fees, including those paid by BIO member companies, from the operation of sequestration.

GMO Answers responds to the toughest questions about GMOs and puts previously hard-to-find health and safety information in one place for the first time.

The Renewable Fuels Standard (RFS) must be maintained in order to spur alternative energy production and mitigate the impacts of over-reliance on oil, according BIO.

In the latest edition of the Food and Drug Policy Forum, an article by Food & Water Watch asserts that FDA is not ready to regulate the world’s first biotech food animal. 

Scott Whitaker has been appointed President of the BIO International Convention.

Adoption of GE soybeans, corn and cotton is at 90 percent or higher.

H.R. 2629 will cut compliance costs for innovative emerging biotech companies

Chimerix President and CEO emphasizes the role of the public market to help finance critical R&D.

BIO welcomes the reopening of USDA's BioPreferred labeling program, which enables consumers to identify certified biobased products.

BIO urges EPA to finalize Tier 3 Motor Vehicle Emissions rules in order to support development of advanced biofuels.

BIO today thanked Sen. Debbie Stabenow (D-Mich.) for introducing the Qualifying Renewable Chemical Production Tax Credit Act of 2013, which reduces taxes for U.S. producers and helps them to commercialize homegrown technology.

Connecticut Governor Dannel Malloy signed into law today, PA 13-183, the GMO food labeling bill.  Connecticut is the first state to require the special labeling of foods containing genetically modified ingredients. 

The President's recently announced Climate Action Plan reiterates support for the Renewable Fuel Standard, and calls for scientists to design new fuels, and farmers to grow new fuels.

BIO applauds Sens. Max Baucus (D-MT) and Orrin Hatch (R-UT) and Reps. Jim Gerlach (R-PA) and Richard Neal (D-MA) on the passage of H.R. 475 to update the existing excise tax to cover the newest seasonal influenza vaccines.

Scientific discoveries have helped to feed the world.

BIO and BIOCOM today thanked Rep. Scott Peters (D-Calif.) for introducing an amendment to the Farm Bill that would make renewable chemicals eligible for the Biorefinery Assistance Program.

The SCOTUS decision represents a departure from judicial and PTO precedent supporting patentability of DNA molecules. The decision could create business uncertainty for a range of inventions.

The 10th Annual World Congress on Industrial Biotechnology will host the Clean Tech Investor Sessions featuring innovative industrial biotechnology companies selected to present to an elite audience of investors and analysts. 

There are several aspects of this report that deserve further scrutiny.

BIO applauded the Senate version of the Farm Bill, which includes robust mandatory funding for Energy Title programs and eligibility for renewable chemicals.

BIO and Delaware Biocommend the State Senate for introducing legislation designed to  address the regulatory issues related to the interchangeability of biological medicines.

Oregon Governor John Kitzhaber signed legislation on Thursday, June 6 designed to address the regulatory issues related to the interchangeability of biological medicines.